Who is sponsoring NCT05483205?

NCT05483205 is sponsored by Cosmetique Active International.

What drugs are being tested in NCT05483205?

Interventions in NCT05483205: Normaderm Phytosolution Double-Correction Daily Care Moisturizer.

What condition does NCT05483205 study?

NCT05483205 studies Acne, Adult.

Is NCT05483205 still recruiting?

NCT05483205 is currently completed. Last updated 2 August 2022.

Last reviewed 2022-08-02 · How we verify

NCT05483205

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Normaderm Phytosolution Global Observational Study

Completed Last updated 2 August 2022

What this trial tests

trial testing Normaderm Phytosolution Double-Correction Daily Care Moisturizer in Acne, Adult in 2,827 participants. Completed in 30 June 2020.

Timeline

1 July 2019

Primary endpoint
30 June 2020

30 June 2020

Quick facts

Lead sponsor	Cosmetique Active International
Status	Completed
Study type	OBSERVATIONAL
Enrollment	2,827
Start date	1 July 2019
Primary completion	30 June 2020
Estimated completion	30 June 2020
Sites	11 locations across Slovakia, Russia, Germany, Hungary, Mexico, Poland, Argentina, Romania

Drugs / interventions tested

Normaderm Phytosolution Double-Correction Daily Care Moisturizer — full drug profile →

Conditions studied

Acne, Adult — all drugs for Acne, Adult →

Sponsor

Cosmetique Active International — full company profile →

Who can join

18 and older, any sex, with Acne, Adult. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this 3-month observational study was to assess, in 2827 adults, the benefit of NP alone or as adjunctive or maintenance care in mild acne, or as adjunctive care in subjects with moderate acne.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cosmetique Active International trials

Trials by the same sponsor.

NCT07239726 — CLINICAL INVESTIGATION TO EVALUATE THE EFFICACY AND SAFETY OF EPILADY PROTOTYPE DEVICE FOLLOWED BY APPLICATION OF A TOPI · NA · not yet recruiting
NCT06590779 — Benefits of a Cosmetic Anti-hair Loss in Males With Hair Loss · NA · not yet recruiting
NCT06516224 — Anti-pigmenting Effect of a Routine of Facial Products in Subjects With Melasma · NA · not yet recruiting
NCT07537595 — Efficacy of Cosmetic Products in Preventing Pigmentation Induced by High Energy Visible Light (HEVL) [400-450nm] · completed
NCT06320314 — Efficacy and Tolerability of Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05483205 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cosmetique Active International
Last refreshed: 2 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05483205.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing